Cell Biology Quiz
19 questions · no time limit
0:00
APPLIED CELL BIOLOGY AND DISEASE
Question 1 of 19
No time limit
Current
Answered
Flagged
Not seen
A biotech company develops a gene therapy vector that delivers a modified version of gene G to cancer cells. The modified gene G produces a protein that retains its normal enzymatic activity but lacks its regulatory domains. In preclinical studies, this therapy causes cancer cell death specifically in tumors that have wild-type gene G, but has no effect on tumors that already have mutated gene G. What does this selective therapeutic effect indicate about gene G's normal function?
YOUR PROGRESS
19
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCDE
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end